Public Release Type:
Journal
Publication Year: 2013
Authors:
Chalasani NP,
Luketic VA,
Siddiqui MS,
Sanyal AJ,
Unalp-Arida A,
Kohli R,
Guy CD,
Yates KP,
Sargeant C,
Boyett SL,
Puri P
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
Nonalcoholic steatohepatitis (NASH) is associated with increased risk of type 2 diabetes, insulin resistance and pancreatic β cell failure. It is not known if resolution of steatohepatitis is associated with improved β cell function.